5'-phospho-2'-deoxyuridine-3'-pyrophosphate(P'->5')adenosine3'-phosphate

ID: ALA1765479

Chembl Id: CHEMBL1765479

PubChem CID: 54585171

Max Phase: Preclinical

Molecular Formula: C19H26N7O17P3

Molecular Weight: 717.37

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)C[C@@H]2OP(=O)(O)OP(=O)(O)O)[C@H]1O

Standard InChI:  InChI=1S/C19H26N7O17P3/c20-16-13-17(22-6-21-16)26(7-23-13)18-14(29)15(9(4-27)40-18)42-45(34,35)38-5-10-8(41-46(36,37)43-44(31,32)33)3-12(39-10)25-2-1-11(28)24-19(25)30/h1-2,6-10,12,14-15,18,27,29H,3-5H2,(H,34,35)(H,36,37)(H2,20,21,22)(H,24,28,30)(H2,31,32,33)/t8-,9+,10+,12+,14+,15+,18+/m0/s1

Standard InChI Key:  IWEVLILPXSDGFO-LNAOLWRRSA-N

Alternative Forms

  1. Parent:

    ALA1765479

    rAdo-P-dUrd-P-P

Associated Targets(non-human)

RNASE1 Ribonuclease pancreatic (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 717.37Molecular Weight (Monoisotopic): 717.0598AlogP: -2.41#Rotatable Bonds: 12
Polar Surface Area: 352.45Molecular Species: ACIDHBA: 19HBD: 8
#RO5 Violations: 3HBA (Lipinski): 24HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.49CX Basic pKa: 7.42CX LogP: -5.48CX LogD: -10.79
Aromatic Rings: 3Heavy Atoms: 46QED Weighted: 0.09Np Likeness Score: 1.10

References

1. Samanta A, Dasgupta S, Pathak T..  (2011)  5'-Modified pyrimidine nucleosides as inhibitors of ribonuclease A.,  19  (7): [PMID:21420869] [10.1016/j.bmc.2010.08.059]

Source